|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0005149,
umls-concept:C0022917,
umls-concept:C0024302,
umls-concept:C0079744,
umls-concept:C0205225,
umls-concept:C0205250,
umls-concept:C0205251,
umls-concept:C0229671,
umls-concept:C0332183,
umls-concept:C0441889,
umls-concept:C0449774,
umls-concept:C0577559,
umls-concept:C1522718,
umls-concept:C1880022
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1995-3-16
|
|
pubmed:abstractText |
Primary mediastinal large cell lymphoma (PMLCL) is an emerging entity. New parameters can help define it.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
5
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
847-9
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:7848887-Adult,
pubmed-meshheading:7848887-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:7848887-Combined Modality Therapy,
pubmed-meshheading:7848887-Disease-Free Survival,
pubmed-meshheading:7848887-Doxorubicin,
pubmed-meshheading:7848887-Female,
pubmed-meshheading:7848887-Humans,
pubmed-meshheading:7848887-L-Lactate Dehydrogenase,
pubmed-meshheading:7848887-Lymphoma, B-Cell,
pubmed-meshheading:7848887-Lymphoma, Large B-Cell, Diffuse,
pubmed-meshheading:7848887-Male,
pubmed-meshheading:7848887-Mediastinal Neoplasms,
pubmed-meshheading:7848887-Radiotherapy,
pubmed-meshheading:7848887-Retrospective Studies,
pubmed-meshheading:7848887-Salvage Therapy,
pubmed-meshheading:7848887-Survival Rate,
pubmed-meshheading:7848887-Treatment Outcome,
pubmed-meshheading:7848887-beta 2-Microglobulin
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Primary mediastinal large cell lymphoma is characterized by an inverted pattern of large tumoral mass and low beta 2 microglobulin levels in serum and frequently elevated levels of serum lactate dehydrogenase.
|
|
pubmed:affiliation |
Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston.
|
|
pubmed:publicationType |
Journal Article
|
